Riociguat for pulmonary arterial hypertension associated with congenital heart disease

Lignende værker

• Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies
  af: Stephan, Rosenkranz, et al.
  Udgivet: (2015)
• Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
  af: Kim, Nick H, et al.
  Udgivet: (2017)
• Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
  af: Saleh, Soundos, et al.
  Udgivet: (2016)
• The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)
  af: Huntgeburth, Michael, et al.
  Udgivet: (2015)
• Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies
  af: Cartin-Ceba, Rodrigo, et al.
  Udgivet: (2018)